Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Mol Carcinog. 2017 Mar 10;56(6):1531–1542. doi: 10.1002/mc.22617

Table 2.

“Non-PKC” phorbol ester/DAG receptors in cancer

Class Isotypes Phorbol ester binding* Activity Roles in cancer

Protein kinase D PKD1 + Protein kinases Diverse roles in promotion or suppression of tumorigenesis and metastasis, primarily in solid tumors
PKD2 +
PKD3 +

RasGRP RasGRP1 + Ras/Rap1 Guanine nucleotide Exchange Factors (GEFs) Diverse roles in oncogenesis of blood cancers and solid tumors
RasGRP2
RasGRP3 +
RasGRP4 +

Chimaerin α1-chimaerin + Rac GTPase Activating Proteins (GAPs) Tumor suppression in glioma and breast cancer
α2-chimaerin +
β1-chimaerin +
β2-chimaerin +
β3-chimaerin +

Munc-13 Munc-13-1 + Coordination of vesicle docking, priming and fusion Unknown
Munc-13-2 ?
Munc-13-3 ?
Munc-13-4 ?

Diacylglycerol-kinase DGKα Lipid kinases Limited knowledge for phorbol ester-responsive DGKs
DGKβ +
DGKγ +
DGKδ
DGKε
DGKη
DGKκ
DGKθ
DGKι
DGKζ
*

Not all DGKs have been examined for phorbol ester binding, but structural predictions on C1 domains suggest that other tan DGKβ and DGKγ all other DGKs should be insensitive to phorbol esters.